NanoPharm's Unattributed Round

NanoPharm raised a round of funding on January 14, 2014.

NanoPharm, dba HylaPharm, has a novel drug-delivery technology that makes treatment of certain types of cancer, including breast cancer and head and neck cancer, both safer and more effective. Using t…

Articles about NanoPharm's Unattributed Round: